Variants of the Aggression-Related RBFOX1 Gene in a Population Representative Birth Cohort Study: Aggressiveness, Personality, and Alcohol Use Disorder.
Por:
Vaht M, Laas K, Fernandez-Castillo N, Kurrikoff T, Kanarik M, Faraone SV, Tooding LM, Veidebaum T, Franke B, Reif A, Cormand B and Harro J
Publicada:
24 nov 2020
Ahead of Print:
24 nov 2020
Categoría:
Psychiatry and mental health
Resumen:
Background: Recently, RBFOX1, a gene encoding an RNA binding protein, has consistently been associated with aggressive and antisocial behavior. Several loci in the gene have been nominally associated with aggression in genome-wide association studies, the risk alleles being more frequent in the general population. We have hence examined the association of four RBFOX1 single nucleotide polymorphisms, previously found related to aggressive traits, with aggressiveness, personality, and alcohol use disorder in birth cohort representative samples. Methods: We used both birth cohorts of the Estonian Children Personality Behavior and Health Study (ECPBHS; original n = 1,238). Aggressiveness was assessed using the Buss-Perry Aggression Questionnaire and the Lifetime History of Aggressiveness structured interview at age 25 (younger cohort) or 33 (older cohort). Big Five personality at age 25 was measured with self-reports and the lifetime occurrence of alcohol use disorder assessed with the MINI interview. RBFOX1 polymorphisms rs809682, rs8062784, rs12921846, and rs6500744 were genotyped in all participants. Given the restricted size of the sample, correction for multiple comparisons was not applied. Results: Aggressiveness was not significantly associated with the RBFOX1 genotype. RBFOX1 rs8062784 was associated with neuroticism and rs809682 with extraversion. Two out of four analyzed RBFOX1 variants, rs8062784 and rs12921846, were associated with the occurrence of alcohol use disorder. Conclusions: In the birth cohort representative sample of the ECPBHS, no association of RBFOX1 with aggressiveness was found, but RBFOX1 variants affected basic personality traits and the prevalence of alcohol use disorder. Future studies on RBFOX1 should consider the moderating role of personality and alcohol use patterns in aggressiveness.
Filiaciones:
Vaht M:
Division of Neuropsychopharmacology, Department of Psychology, Estonian Center of Behavioral and Health Sciences, University of Tartu, Tartu, Estonia
Laas K:
Division of Neuropsychopharmacology, Department of Psychology, Estonian Center of Behavioral and Health Sciences, University of Tartu, Tartu, Estonia
Fernandez-Castillo N:
Departament de Genètica, Microbiologia i Estadística, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain
Institut de Biomedicina de la Universitat de Barcelona (IBUB), Barcelona, Spain
Institut de Recerca Sant Joan de Déu (IR-SJD), Esplugues de Llobregat, Spain
Kurrikoff T:
Institute of Social Studies, University of Tartu, Tartu, Estonia
Kanarik M:
Division of Neuropsychopharmacology, Department of Psychology, Estonian Center of Behavioral and Health Sciences, University of Tartu, Tartu, Estonia
Faraone SV:
Departments of Psychiatry and of Neuroscience and Physiology, The State University of New York Upstate Medical University, Syracuse, NY, United States
Tooding LM:
Institute of Social Studies, University of Tartu, Tartu, Estonia
Veidebaum T:
National Institute for Health Development, Estonian Center of Behavioral and Health Sciences, Tallinn, Estonia
Franke B:
Department of Human Genetics, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behavior, Nijmegen, Netherlands
Reif A:
Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt Goethe University, Frankfurt am Main, Germany
Cormand B:
Departament de Genètica, Microbiologia i Estadística, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain
Institut de Biomedicina de la Universitat de Barcelona (IBUB), Barcelona, Spain
Institut de Recerca Sant Joan de Déu (IR-SJD), Esplugues de Llobregat, Spain
Harro J:
Division of Neuropsychopharmacology, Department of Psychology, Estonian Center of Behavioral and Health Sciences, University of Tartu, Tartu, Estonia
Green Published, gold
|